Beyond polemics: science and ethics of ADHD (Q22251019)

Erratum: Beyond polemics: science and ethics of ADHD

Europe PubMed Central

title

Beyond polemics: science and ethics of ADHD (English)

0 references

main subject

research ethics

0 references

corrigendum / erratum

0 references

Ilina Singh

1

Ilina

Singh

1 reference

Dimensions Publication ID

Dimensions

1052142695

Nature Reviews Neuroscience

7 February 2023

language of work or name

English

0 references

publication date

December 2008

0 references

published in

0 references

volume

9

0 references

issue

12

0 references

page(s)

957-964

0 references

cites work

Global consensus on ADHD/HKD.

1 reference

Who first suggests the diagnosis of attention-deficit/hyperactivity disorder?

31 March 2020

1 reference

Who receives a diagnosis of attention-deficit/ hyperactivity disorder in the United States elementary school population?

31 March 2020

1 reference

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis

31 March 2020

1 reference

Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence

31 March 2020

1 reference

Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children

31 March 2020

1 reference

Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial.

31 March 2020

1 reference

Etiologic Classification of Attention-Deficit/Hyperactivity Disorder

31 March 2020

1 reference

Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder.

31 March 2020

1 reference

Gene-environment interplay and psychopathology: multiple varieties but real effects

31 March 2020

1 reference

Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways

31 March 2020

1 reference

The global market for ADHD medications.

31 March 2020

1 reference

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

31 March 2020

1 reference

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

31 March 2020

1 reference

Attention-deficit/hyperactivity disorder in a diverse culture: do research and clinical findings support the notion of a cultural construct for the disorder?

31 March 2020

1 reference

Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder

31 March 2020

1 reference

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

31 March 2020

1 reference

Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder.

31 March 2020

1 reference

The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder

31 March 2020

1 reference

Can neuroscience be integrated into the DSM-V?

31 March 2020

1 reference

Annotation: The use of psychotropic medications in children: a British view

31 March 2020

1 reference

Genetic basis of attention deficit and hyperactivity

31 March 2020

1 reference

Evidence and belief in ADHD.

31 March 2020

1 reference

The Neurobiology of Attention-Deficit/Hyperactivity Disorder

31 March 2020

1 reference

Genetic aspects in attention-deficit/hyperactivity disorder

31 March 2020

1 reference

Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications

31 March 2020

1 reference

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes

31 March 2020

1 reference

Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).

31 March 2020

1 reference

Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis

31 March 2020

1 reference

The endophenotype concept in psychiatry: etymology and strategic intentions

31 March 2020

1 reference

Temperament and attention deficit hyperactivity disorder: the development of a multiple pathway model

31 March 2020

1 reference

Working toward a neurobiological account of ADHD: commentary on Gail Tripp and Jeff Wickens, dopamine transfer deficit

31 March 2020

1 reference

Reprint of "Neurobiology of animal models of attention-deficit hyperactivity disorder".

31 March 2020

1 reference

The attention system of the human brain

31 March 2020

1 reference

Structural brain imaging of attention-deficit/hyperactivity disorder

31 March 2020

1 reference

Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions

31 March 2020

1 reference

Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder

31 March 2020

1 reference

Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

31 March 2020

1 reference

Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD.

31 March 2020

1 reference

Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD

31 March 2020

1 reference

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function

31 March 2020

1 reference

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

31 March 2020

1 reference

Academic and educational outcomes of children with ADHD.

31 March 2020

1 reference

Attention-deficit hyperactivity disorder

31 March 2020

1 reference

The shifting engines of medicalization.

31 March 2020

1 reference

Is childhood hyperactivity the product of western culture?

31 March 2020

1 reference

Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter?

31 March 2020

1 reference

Psychiatric disorders as social constructs: ADHD as a case in point

31 March 2020

1 reference

Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

31 March 2020

1 reference

The logic behind a multimethod intervention to improve adherence to clinical practice guidelines in a nationwide network of primary care practices.

31 March 2020

1 reference

Pathways to "evidence-informed" policy and practice: a framework for action

31 March 2020

1 reference

Determinants of innovation within health care organizations: literature review and Delphi study.

31 March 2020

1 reference

Influences on GPs' decision to prescribe new drugs-the importance of who says what

31 March 2020

1 reference

Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

31 March 2020

1 reference

Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder

31 March 2020

1 reference

Barriers to detection, help-seeking, and service use for children with ADHD symptoms

31 March 2020

1 reference

ADHD service use patterns in youth

31 March 2020

1 reference

The role of care location in diagnosis and treatment of pediatric psychosocial conditions.

31 March 2020

1 reference

Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder

31 March 2020

1 reference

The "achievement by proxy" spectrum: recognition and clinical response to pressured and high-achieving children and adolescents

31 March 2020

1 reference

Doing their jobs: mothering with Ritalin in a culture of mother-blame.

31 March 2020

1 reference

Psychiatric genetics: The brains of the family.

31 March 2020

1 reference

Patients' resistance to risk information in genetic counseling for BRCA1/2.

31 March 2020

1 reference

Delinquent Behavior and Emerging Substance Use in the MTA at 36 Months: Prevalence, Course, and Treatment Effects

31 March 2020

1 reference

Research review: DSM-V conduct disorder: research needs for an evidence base

31 March 2020

1 reference

Biomarkers trump behavior in mental illness diagnosis.

31 March 2020

1 reference

Susceptibility genes and the question of embodied identity

31 March 2020

1 reference

Trends in the prescribing of psychotropic medications to preschoolers

31 March 2020

1 reference

Concomitant psychotropic medication for youths

31 March 2020

1 reference

Recent child pharmacoepidemiological findings.

31 March 2020

1 reference

Clinical implications of ethical concepts: moral self-understandings in children taking methylphenidate for ADHD.

31 March 2020

1 reference

The Goulstonian Lectures ON SOME ABNORMAL PSYCHICAL CONDITIONS IN CHILDREN

31 March 2020

1 reference

The Goulstonian Lectures ON SOME ABNORMAL PSYCHICAL CONDITIONS IN CHILDREN

31 March 2020

1 reference

Effects of stimulant medication on cognitive performance of children with ADHD.

31 March 2020

1 reference

Illicit use of prescribed stimulant medication among college students

31 March 2020

1 reference

Patterns and knowledge of nonmedical use of stimulants among college students

31 March 2020

1 reference

Poll results: look who's doping

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRN2514

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1052142695

0 references

Fatcat ID

release_hpdyrrbnnvdhxdsqjjavbeqfbm

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19020513

1 reference

Consolidated OpenCitations Corpus – April 2017